AQP4 expression depends on a sequence of linked cellular events. Gene transcription generates AQP4 mRNA, which is translated into the channel protein, while membrane-trafficking and anchoring mechanisms position that protein at astrocyte endfeet. Examining these stages separately helps researchers determine whether altered AQP4 reflects changes in production, delivery to the membrane, or retention at the blood–brain barrier.
Location is as important as protein production. Concentrating AQP4 in astrocyte endfeet places the water channel at a key interface associated with the blood–brain barrier, allowing its distribution to contribute to central nervous system fluid regulation. A change in placement could therefore alter water handling even when total AQP4 production does not change in the same way.
AQP4-directed autoantibodies provide an immunological context for studying neuromyelitis optica. Their association with astrocyte damage links an immune response against AQP4 with disrupted water transport, edema, and neurological disease. Measuring expression and localization alongside antibody-related effects can help connect molecular changes in astrocytes with tissue-level consequences in the central nervous system.
A useful assessment considers both how much AQP4 is produced and where it is positioned. AQP4 mRNA reflects transcriptional output, while the protein and its distribution at astrocyte endfeet provide information about translation and membrane placement. Comparing these features with normal tissue can help distinguish altered fluid regulation from changes associated with inflammation, infection, or injury.
Interpretation requires comparison with the expected astrocyte pattern rather than relying on a single expression value. Differences in AQP4 production or endfoot placement may indicate disrupted water regulation, but their significance depends on the surrounding context of neuroinflammation, infection, or tissue injury. This approach helps relate molecular observations to edema and astrocyte damage without treating every change as equivalent.
In immunology and infection research, AQP4 expression connects astrocyte biology with inflammatory and tissue responses in the central nervous system. Expression measurements can reveal whether water-regulatory features change during neuroinflammation, infection, or injury, while AQP4-directed autoantibodies provide a disease-specific immune context through neuromyelitis optica. Together, these observations support analysis of edema, astrocyte damage, and neurological outcomes.